These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16551646)

  • 1. Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration.
    Liu X; Sullivan KA; Madl JE; Legare M; Tjalkens RB
    Toxicol Sci; 2006 Jun; 91(2):521-31. PubMed ID: 16551646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of manganese exposure-induced dopaminergic toxicity.
    Prabhakaran K; Ghosh D; Chapman GD; Gunasekar PG
    Brain Res Bull; 2008 Jul; 76(4):361-7. PubMed ID: 18502311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxisome proliferator-activated receptor-gamma agonist 1,1-bis(3'-indolyl)-1-(p-trifluoromethylphenyl)methane suppresses manganese-induced production of nitric oxide in astrocytes and inhibits apoptosis in cocultured PC12 cells.
    Tjalkens RB; Liu X; Mohl B; Wright T; Moreno JA; Carbone DL; Safe S
    J Neurosci Res; 2008 Feb; 86(3):618-29. PubMed ID: 18041089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
    Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
    Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese does not alter the severe neurotoxicity of MPTP.
    Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
    Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB-dependent production of nitric oxide by astrocytes mediates apoptosis in differentiated PC12 neurons following exposure to manganese and cytokines.
    Liu X; Buffington JA; Tjalkens RB
    Brain Res Mol Brain Res; 2005 Nov; 141(1):39-47. PubMed ID: 16168523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
    Itzhak Y; Martin JL; Ali SF
    Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene deletion of nos2 protects against manganese-induced neurological dysfunction in juvenile mice.
    Streifel KM; Moreno JA; Hanneman WH; Legare ME; Tjalkens RB
    Toxicol Sci; 2012 Mar; 126(1):183-92. PubMed ID: 22174044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrastriatal manganese chloride exposure causes acute locomotor impairment as well as partial activation of substantia nigra GABAergic neurons.
    Yang Y; An J; Wang Y; Luo W; Wang W; Mei X; Wu S; Chen J
    Environ Toxicol Pharmacol; 2011 Jan; 31(1):171-8. PubMed ID: 21787683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism.
    Zhao F; Cai T; Liu M; Zheng G; Luo W; Chen J
    Toxicol Sci; 2009 Jan; 107(1):156-64. PubMed ID: 18836210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
    Iravani MM; Leung CC; Sadeghian M; Haddon CO; Rose S; Jenner P
    Eur J Neurosci; 2005 Jul; 22(2):317-30. PubMed ID: 16045485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese augments nitric oxide synthesis in murine astrocytes: a new pathogenetic mechanism in manganism?
    Spranger M; Schwab S; Desiderato S; Bonmann E; Krieger D; Fandrey J
    Exp Neurol; 1998 Jan; 149(1):277-83. PubMed ID: 9454637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
    Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
    Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway.
    Gomes MZ; Raisman-Vozari R; Del Bel EA
    Brain Res; 2008 Apr; 1203():160-9. PubMed ID: 18313645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manganese-induced NF-kappaB activation and nitrosative stress is decreased by estrogen in juvenile mice.
    Moreno JA; Streifel KM; Sullivan KA; Hanneman WH; Tjalkens RB
    Toxicol Sci; 2011 Jul; 122(1):121-33. PubMed ID: 21512103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H; Kurosaki R; Oki C; Araki T
    Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
    Schintu N; Frau L; Ibba M; Caboni P; Garau A; Carboni E; Carta AR
    Eur J Neurosci; 2009 Mar; 29(5):954-63. PubMed ID: 19245367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.